Can a pill turn back the clock? scientists test Anti-Aging drugs in seniors
NCT ID NCT06658093
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study is testing two drugs, rapamycin and everolimus, in 194 healthy adults aged 65 to 90. The goal is to find a safe dose and timing that can reduce a key aging signal in cells to levels seen in younger people. The researchers also want to see if the best dose differs between men and women.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rapamycin (sirolimus) and everolimus (Afinitor), both mTOR inhibitors
What this could lead to
If successful, this study could identify safe doses of these drugs that mimic the cellular activity of younger people, potentially pointing toward a way to slow aging and reduce age-related diseases.
What could go wrong
This is a very early, exploratory trial focused on dosing and safety, not on proving that the drugs actually slow aging in humans. The results may not translate to real-world benefits, and mTOR inhibitors have known side effects like immune suppression and mouth sores.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center at San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••